These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6524165)

  • 1. [Prevention of the chronic persistence of typhoid microbes in rabbits with thymostimulin].
    Zaritskiĭ AM; Fil'chakov IV; Kruglov IuV; Nikol'skiĭ IS; Viter SS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):67-9. PubMed ID: 6524165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of immunomodulating treatment (thymostimulin) in chronic obstructive pulmonary disease.
    Banos V; Gómez J; García A; Ruiz J; Alvarez R; Lorenzo M; Canteras M; Valdés M
    Respiration; 1997; 64(3):220-3. PubMed ID: 9154674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thymostimulin in chronic hepatitis B virus infection].
    Mas A; Bruguera M; Costa J; Sánchez Tapias JM
    Med Clin (Barc); 1987 Sep; 89(9):398-9. PubMed ID: 3669798
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunostimulation in heart surgery: thymostimulin. Preliminary data].
    Maccherini M; Davoli G; Sani G; Miraldi F; Gotti G; Toscano M
    Minerva Chir; 1993 Dec; 48(23-24):1445-8. PubMed ID: 8177449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Participation of the thymus in the mechanism of bacterial discharge in carriers of typhoid bacteria].
    Lerenman MIa; Nevskiĭ MV; Vedenskaia VA; Oster NR; Abidov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):99-103. PubMed ID: 1024452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of immunostimulants on the resistance of white mice to the causative agent of typhoid fever].
    Sviridov LP; Stepanov AV; Konikova RE; Ustinov BS
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):70-3. PubMed ID: 2385993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymostimulin in treatment of psoriasis.
    Pedragosa R; Vidal J
    Arch Dermatol; 1986 Jun; 122(6):624. PubMed ID: 3717970
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of thymostimulin.
    Bertarelli F
    Lancet; 1994 Jan; 343(8890):184. PubMed ID: 7904038
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunomodulating therapy in high-risk urologic surgery. The results with thymostimulin].
    Borsa R; Gamba P; Governa M; Polledro P; Fontana G
    Recenti Prog Med; 1993 May; 84(5):357-8. PubMed ID: 8511394
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of thymostimulin.
    Steward WP
    Lancet; 1994 Jan; 343(8890):184. PubMed ID: 7904039
    [No Abstract]   [Full Text] [Related]  

  • 11. [Postoperative infections: the use of thymostimulin (TP1) in patients at risk].
    Lai N; Lavosi V; Pinna S; Salis G; Colombo E; Vargiu P
    G Chir; 1992; 13(6-7):377-8. PubMed ID: 1389989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The possibility of the restoration of interferon formation by biologically active thymus factors in experimentally induced immunodepression].
    Chernenko OD; Grinevich IuA
    Vopr Virusol; 1991; 36(4):309-10. PubMed ID: 1724585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy with high-dose thymostimulin in patients with advanced neoplasms].
    Marcellino LR; Stellato L; Franchi F; Bandini M; Ceccarelli P; Agatensi L
    G Ital Oncol; 1988; 8(1):45-7. PubMed ID: 3220512
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of infection and improvement of cenesthesia with thymostimulin during chemotherapy following mastectomy].
    Alba E; Visentin L; Farina C; Wierdis T
    Minerva Ginecol; 1991 Dec; 43(12):585-7. PubMed ID: 1819777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoprophylaxis with thymostimulin in oncological surgery.
    Russello D; Puleo S; Succi L; Di Cataldo A; Scuideri M; Scilletta B; Di Blasi M; Guastella T; Latteri F
    J Chemother; 1989 Jul; 1(4 Suppl):1307-8. PubMed ID: 16312878
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of the formation of the infectious process with biologically active thymic factors in the Salmonella typhimurium challenge of mice coincident with macrophage activation].
    Grinevich IuA; Zaritskiĭ AM; Fil'chakov IV; Fil'chakov FV; Nikol'skiĭ IS
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Dec; (12):71-4. PubMed ID: 3328454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial response of metastatic hepatocellular carcinoma after treatment with thymostimulin.
    Palmieri G; Gridelli C; Pepe R; Airoma G; Iaffaioli RV; Frasci G; Caponigro F; Bianco AR
    Tumori; 1990 Feb; 76(1):61-3. PubMed ID: 2157309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymostimulin treatment in cases of AIDS and ARC.
    Raise E; Bonazzi L; Di Giandomenico G; Sabbatini S; Schiattone ML; Di Pede B; Gallo R; Savoia M; Martuzzi M
    J Exp Pathol; 1987; 3(4):745-50. PubMed ID: 3454812
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of thymostimulin on chemotherapy-induced toxicity and long-term survival in small cell lung cancer patients.
    Macchiarini P; Danesi R; Del Tacca M; Angeletti CA
    Anticancer Res; 1989; 9(1):193-6. PubMed ID: 2539772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of interleukin-2 and gamma-interferon production in vitro on cord blood lymphocytes and in vivo on primary cellular immunodeficiency patients with thymic extract (thymostimulin).
    Lin CY; Kuo YC; Lin CC; Ou BR
    J Clin Immunol; 1988 Mar; 8(2):103-7. PubMed ID: 3131384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.